Literature DB >> 11145505

Barrett's metaplasia.

J A Jankowski1, R F Harrison, I Perry, F Balkwill, C Tselepis.   

Abstract

The rate of oesophageal adenocarcinoma is increasing in the western world and has a poor prognosis mainly because individuals present at a late stage. Attempts to intervene at an early stage of tumour progression have not proven cost effective, although lesions identified during surveillance programmes have a better prognosis. As a consequence, there has been renewed interest in strategies that might prevent the precursor lesion Barrett's oesophagus. Furthermore, there is an improved understanding of genetic and environmental interactions necessary for the clonal expansion and propagation of metaplastic premalignant lesions. Clearly, three mechanisms promote cancer progression--inheritance of germ-line mutations or polymorphisms, sporadic mutagenesis, and local epigenetic alterations. Locally produced cytokines and bile acids in the refluxate create a microenvironment that sets the scene for metaplastic transformation of the oesophageal epithelium, mainly by directly affecting metaplastic stem cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11145505     DOI: 10.1016/S0140-6736(00)03411-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  100 in total

1.  Minichromosome maintenance (MCM) proteins may be pre-cancer markers.

Authors:  M R Alison; T Hunt; S J Forbes
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

2.  Surveillance for Barrett's oesophagus. The conundrum of Barrett's oesophagus is changing.

Authors:  J A Eksteen; J A Jankowski
Journal:  BMJ       Date:  2001-05-05

3.  Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer.

Authors:  H Barr
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

4.  Plasma and esophageal mucosal levels of vitamin C: role in the pathogenesis and neoplastic progression of Barrett's esophagus.

Authors:  A Fountoulakis; I G Martin; K L M White; M F Dixon; J E Cade; H M Sue-Ling; C P Wild
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

5.  Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.

Authors:  Michael Quante; Govind Bhagat; Julian A Abrams; Frederic Marache; Pamela Good; Michele D Lee; Yoomi Lee; Richard Friedman; Samuel Asfaha; Zinaida Dubeykovskaya; Umar Mahmood; Jose-Luiz Figueiredo; Jan Kitajewski; Carrie Shawber; Charles J Lightdale; Anil K Rustgi; Timothy C Wang
Journal:  Cancer Cell       Date:  2012-01-17       Impact factor: 31.743

Review 6.  Magnifying endoscopy in upper gastroenterology for assessing lesions before completing endoscopic removal.

Authors:  Ning-Li Chai; En-Qiang Ling-Hu; Yoshinori Morita; Daisuke Obata; Takashi Toyonaga; Takeshi Azuma; Ben-Yan Wu
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

7.  Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium.

Authors:  H Kazumori; S Ishihara; M A K Rumi; Y Kadowaki; Y Kinoshita
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

8.  Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line.

Authors:  Peter C Konturek; Grzegorz Burnat; Tilman Rau; Eckhart G Hahn; Stanislaw Konturek
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

9.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

10.  Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation.

Authors:  Ahmed Madisch; Stephan Miehlke; Ekkehard Bayerdorffer; Birgit Wiedemann; David Antos; Anke Sievert; Michael Vieth; Manfred Stolte; Heinrich Schulz
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.